About 200 reports

  • 6.2.2 CLINICAL PRACTICE

IMRT HAS HELPED TO DECREASE THE OCCURRENCE OF GASTROINTESTINAL (GI) TOXICITIES USUALLY ASSOCIATED WITH EBRT.

  • Hormone
  • Hospital
  • Managed Care
  • Prostate Cancer
  • Therapy

Therapy Area Central Nervous System Dermatology Gastrointestinal Genetic Disorders Hematological Disorders Immunology Musculoskeletal Oncology Other Diseases No. of Deals ## ## ## ## ## ## ## ## ## Deal Value (US$ million) NA NA

  • Dementia
  • Healthcare
  • Hormone
  • Managed Care
  • United States

The auto exports exceeded over ## million each year.

  • Hormone
  • Managed Care
  • China
  • AstraZeneca Pharmaceutical Co., Ltd
  • Bristol-Myers Squibb Company

In April, Spectrum Health System named as one of the ## top health systems.

  • Hospital
  • Managed Care
  • United States
  • Company
  • Supply
  • Serotonin Modulators and Stimulators

THE AUTO EXPORTS EXCEEDED OVER ## MILLION EACH YEAR.

  • Antidepressant
  • Hormone
  • Therapy
  • China
  • Demand

They have sixty plus products on market, covering categories of gastrointestinal, cardiovascular, anti-tumor, and antibiotics. - Haitian International Trading Co., Ltd.

  • Hormone
  • Managed Care
  • China
  • Supply
  • Zhejiang Expressway Co., Ltd.

AMONG THE MAJOR ## MANUFACTURERS, ## IN GUANGDONG PROVINCE, ## IN SHANGHAI, ## IN ZHEJIANG PROVINCE, ## IN ANHUI PROVINCE, ## IN BEIJING AND ## IN HUBEI PROVINCE.

  • Hormone
  • Managed Care
  • China
  • East Asia
  • Zhejiang Expressway Co., Ltd.

The company produces and markets high-quality products and biologics in the areas of gastrointestinal disease, neurology, psychiatry, immunology, pain control, infectious disease, and oncology.

  • Hormone
  • Managed Care
  • China
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd

They have sixty plus products on market, covering categories of gastrointestinal, cardiovascular, anti-tumor, and antibiotics. - Haitian International Trading Co., Ltd.

  • Hormone
  • China
  • Nanjing Aosaikang Medicinal Group
  • Zhejiang Expressway Co., Ltd.
  • Zhejiang Hisun Pharmaceutical Co., Ltd.

The company produces and markets high-quality products and biologics in the areas of gastrointestinal disease, neurology, psychiatry, immunology, pain control, infectious disease, and oncology.

  • Hormone
  • Managed Care
  • China
  • Bayer Schering Pharmaceutical Co., Ltd
  • Roche Group

This enables the drug to bypass the gastrointestinal tract.

  • Hormone
  • AbbVie Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Pfizer Inc.
  • Benazepril is prescribed off-label in both dogs and cats to treat CHF.

NSAIDS are associated with gastrointestinal ulcers/ perforations, and kidney and liver toxicity.

  • Hormone
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Merial Limited
  • Zoetis Inc.

The company' s digestive health products include diagnostics and therapeutics, gastrointestinal endoscopy products, enteral feeding tubes and accessories.

  • Respiratory Monitoring
  • Eastern Europe
  • Russia
  • Forecast
  • CareFusion Corporation

AMONG THE MAJOR ## MANUFACTURERS, ## IN GUANGDONG PROVINCE, ## IN SHANGHAI, ## IN ZHEJIANG PROVINCE, ## IN ANHUI PROVINCE, ## IN BEIJING AND ## IN HUBEI PROVINCE.

  • Hormone
  • China
  • Pfizer Inc.
  • Zhejiang Expressway Co., Ltd.
  • Zhejiang Xianju Pharmaceutical Co., Ltd

Drivers and their Impact Driver Impact on Key Customer Category Diagnostic Clinics High Incidence of Chronic Diseases and Reproductive System Disorders Hospitals Low Low ## ## ## ## ## High Low ## ## ## ## ## High High High Low Low Low ## ## ## ## ## High Low ## ## ## ## ## High

  • Diagnostics
  • Healthcare
  • Hormone
  • Immunochemistry Test
  • In Vitro Diagnostics
  • has been approved unanimously by the Boards of Directors of both Shire and NPS Pharma.
  • Glucagon Like Peptide 2 Receptor (GLP2R) - Dormant Products

Report covers products from therapy areas Gastrointestinal, Toxicology and Metabolic Disorders which include indications Short Bowel Syndrome, Chemotherapy Effects, Diarrhea, Gastrointestinal Mucositis, Obesity and Type ## Diabetes.

  • Hormone
  • Therapy
  • United States
  • World
  • Product Initiative
  • NEW DEVELOPMENTS IN HORMONE DRUG DELIVERY

By avoiding the gastrointestinal system, the drug is less likely to cause nausea.

  • Hormone
  • Generex Biotechnology Corporation
  • Nitto Denko Corporation
  • Noven Pharmaceuticals, Inc.
  • Teva Pharmaceutical Industries Ltd.

References P##(SHC) Therapeutic Area/ Disease Indications Diabetes Gastrointestinal lesions University of Bari Aldo Moro, Italy.

  • Hormone
  • Insulin
  • United States
  • MC2 Biotek Group
  • POXEL SA
  • CLINICAL TRIAL PROFILE SNAPSHOTS

The prominent features of this report are - ##.

  • Chronic Disease
  • Hormone
  • World
  • Product Initiative
  • Allergan plc
  • provides an assessment of J&J's prostate cancer portfolio.
  • J&J'S PROSTATE CANCER PORTFOLIO ASSESSMENT, 2014

PLoS One; ##(##): e##.

  • Hormone
  • Managed Care
  • Astellas Pharma Inc.
  • Bayer AG
  • PROVENGE group
  • Section 2 - Company Analysis

According to the International Foundation for Functional Gastrointestinal Disorders, IBS is the most common functional gastrointestinal disorder.

  • Hormone
  • Pharmaceutical
  • United States
  • Company
  • Ferring International Center S.A.
  • ASTRAZENECA ENTERS INTO CO-DEVELOPMENT AGREEMENT WITH IRONWOOD PHARMA FOR LINACLOTIDE
  • EQUITY OFFERING

Linaclotide Delayed Release-## (DR##).

  • Hormone
  • Pharmaceutical
  • United States
  • Company Financials
  • Ironwood Pharmaceuticals, Inc.

Drivers and their Impact Impact on End-user Category Driver Expiry of Patents Increased Investment in Healthcare Infrastructure Hospitals Low Low ## ## ## ## ## High Low Pharmaceutical Stores High ## ## ## ## ## High Low High ## ## ## ## ## ## ## ## ## ## Cost Factor Increase in Elde

  • Anti-Infective
  • Hormone
  • Japan
  • Meiji Seika Pharma Co., Ltd.
  • Nipro Corporation
  • Clinical Trial profile. 79 Trial Title
  • Target

Constipation Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Constipation Global Clinical Trials Review, H1, 2017" provides an overview of Constipation clinical trials scenario. This report provides top line data relating to the clinical trials on Constipation. Report includes an...

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Hormone
  • Pharmaceutical
  • Lipocine Completes Private Placement Of Shares For US$37.8 Million
  • Lipocine Raises USD34.8 Million in Public Offering of Common Stock

Its Lip' ral is a technology based on lipidic compositions that form optimal dispersed phase in the gastrointestinal environment.

  • Hormone
  • United States
  • Company
  • Company Operations
  • Lipocine Inc.
  • Glucagon-Like Peptide 2 Receptor (GLP-2 Receptor or GLP2R) - Dormant Projects
  • Pipeline by Shire Plc, H1 2016

The molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are ##, ##, ## and ## respectively.

  • Hormone
  • Therapy
  • World
  • Product Initiative
  • NPS Pharmaceuticals, Inc.
  • PRODUCTS UNDER DEVELOPMENT BY UNIVERSITIES/INSTITUTES, H2 2018 (CONTD..1), H2 2018
  • OSTEOPOROSIS - PIPELINE BY RICHTER GEDEON NYRT, H2 2018

It also offers products to treat gastrointestinal disorders, neurodegenerative pathologies and rheumatology diseases.

  • Hormone
  • Managed Care
  • Monoclonal Antibody
  • Company
  • Product Initiative
  • Secondary Hyperparathyroidism - Drug Profiles
  • evocalcet - Drug Profile

The molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are ##, ##, ## and ## respectively.

  • Endocrine Disease
  • Hormone
  • Therapy
  • United States
  • EA Pharma Co., Ltd.
  • DA-6886 - DRUG PROFILE
  • RQ-00000010 - DRUG PROFILE

Study subjects will be randomized in a ##:##:## ratio, receiving either ## mg of SYN-##, ## mg of SYN-##, or placebo.

  • Hormone
  • Managed Care
  • Pharmaceutical
  • United States
  • Product Initiative
  • Secondary Hyperparathyroidism - Pipeline by Shire Plc, H1 2018
  • Featured News & Press Releases

The molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I and Preclinical stages are ##, ##, ##, ## and ## respectively.

  • Endocrine Disease
  • Hormone
  • United States
  • Product Initiative
  • Kyowa Hakko Kirin Co., Ltd.